Exciting trial for PNH patients

A trial of a new treatment that could bring a major boost to patients who have a rare condition is being done by the research and development team.

The debilitating haematological condition PNH currently requires a vital drug infusion every two weeks, for life. The drug being tested by five patients at Monklands Hospital only needs to be delivered every two months – a prospect that is exciting PNH patients across the UK.

We are the only place in Scotland offering the trial.

Comments are closed.